Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening

BACKGROUND & AIMS: A variety of fecal immunochemical tests (FITs) for hemoglobin (Hb) are used in colorectal cancer screening. It is unclear to what extent differences in reported sensitivities and specificities reflect true heterogeneity in test performance or differences in study populations o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gies, Anton (VerfasserIn) , Cuk, Katarina (VerfasserIn) , Schrotz-King, Petra (VerfasserIn) , Brenner, Hermann (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Gastroenterology
Year: 2018, Jahrgang: 154, Heft: 1, Pages: 93-104
ISSN:1528-0012
DOI:10.1053/j.gastro.2017.09.018
Online-Zugang:Verlag, Pay-per-use, Volltext: http://dx.doi.org/10.1053/j.gastro.2017.09.018
Volltext
Verfasserangaben:Anton Gies, Katarina Cuk, Petra Schrotz-King, and Hermann Brenner

MARC

LEADER 00000caa a2200000 c 4500
001 1567597440
003 DE-627
005 20220814063029.0
007 cr uuu---uuuuu
008 180125s2018 xx |||||o 00| ||eng c
024 7 |a 10.1053/j.gastro.2017.09.018  |2 doi 
035 |a (DE-627)1567597440 
035 |a (DE-576)497597446 
035 |a (DE-599)BSZ497597446 
035 |a (OCoLC)1340986293 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gies, Anton  |d 1987-  |e VerfasserIn  |0 (DE-588)1151332208  |0 (DE-627)101156713X  |0 (DE-576)49759837X  |4 aut 
245 1 0 |a Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening  |c Anton Gies, Katarina Cuk, Petra Schrotz-King, and Hermann Brenner 
264 1 |c 2018 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.01.2018 
500 |a Article was first available online on 25 September 2017 
520 |a BACKGROUND & AIMS: A variety of fecal immunochemical tests (FITs) for hemoglobin (Hb) are used in colorectal cancer screening. It is unclear to what extent differences in reported sensitivities and specificities reflect true heterogeneity in test performance or differences in study populations or varying pre-analytical conditions. We directly compared the sensitivity and specificity values with which 9 quantitative (laboratory-based and point-of-care) FITs detected advanced neoplasms (AN) in a single colorectal cancer screening study. METHODS: Pre-colonoscopy stool samples were obtained from participants of screening colonoscopy in Germany from 2005 through 2010 and frozen at -80°C until analysis. The stool samples were thawed, homogenized, and used for 9 different quantitative FITs in parallel. Colonoscopy and histology reports were collected from all participants and evaluated by 2 independent, trained research assistants who were blinded to the test results. Comparative evaluations of diagnostic performance for AN were made at preset manufacturers' thresholds (range, 2.0-17.0 μg Hb/g feces), at a uniform threshold (15 μg Hb/g feces), and at adjusted thresholds yielding defined levels of specificity (99%, 97%, and 93%). RESULTS: Of the 1667 participants who fulfilled the inclusion criteria, all cases with AN (n = 216) and 300 randomly selected individuals without AN were included in the analysis. Sensitivities and specificities for AN varied widely when we used the preset thresholds (21.8%-46.3% and 85.7%-97.7%, respectively) or the uniform threshold (16.2%-34.3% and 94.0%-98.0%, respectively). Adjusting thresholds to yield a specificity of 99%, 97%, or 93% resulted in almost equal sensitivities for detection of AN (14.4%-18.5%, 21.3%-23.6%, and 30.1%-35.2%, respectively) and almost equal positivity rates (2.8%-3.4%, 5.8%-6.1%, and 10.1%-10.9%, respectively). CONCLUSIONS: Apparent heterogeneity in diagnostic performance of quantitative FITs can be overcome to a large extent by adjusting thresholds to yield defined levels of specificity or positivity rates. Rather than simply using thresholds recommended by the manufacturer, screening programs should choose thresholds based on intended levels of specificity and manageable positivity rates. 
650 4 |a Advanced Adenoma 
650 4 |a Colon Cancer 
650 4 |a Early Detection 
650 4 |a Fecal Occult Blood Test 
700 1 |a Cuk, Katarina  |d 1985-  |e VerfasserIn  |0 (DE-588)1046823701  |0 (DE-627)777096609  |0 (DE-576)400153750  |4 aut 
700 1 |a Schrotz-King, Petra  |e VerfasserIn  |0 (DE-588)1078258066  |0 (DE-627)838209327  |0 (DE-576)450367118  |4 aut 
700 1 |a Brenner, Hermann  |e VerfasserIn  |0 (DE-588)1020516445  |0 (DE-627)691247005  |0 (DE-576)360642136  |4 aut 
773 0 8 |i Enthalten in  |t Gastroenterology  |d New York, NY : Elsevier, 1949  |g 154(2018), 1, Seite 93-104  |h Online-Ressource  |w (DE-627)270937293  |w (DE-600)1478699-0  |w (DE-576)078590221  |x 1528-0012  |7 nnas  |a Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening 
773 1 8 |g volume:154  |g year:2018  |g number:1  |g pages:93-104  |g extent:12  |a Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening 
856 4 0 |u http://dx.doi.org/10.1053/j.gastro.2017.09.018  |x Verlag  |x Resolving-System  |z Pay-per-use  |3 Volltext 
951 |a AR 
992 |a 20180125 
993 |a Article 
994 |a 2018 
998 |g 1020516445  |a Brenner, Hermann  |m 1020516445:Brenner, Hermann  |d 850000  |d 851600  |d 50000  |e 850000PB1020516445  |e 851600PB1020516445  |e 50000PB1020516445  |k 0/850000/  |k 1/850000/851600/  |k 0/50000/  |p 4  |y j 
998 |g 1078258066  |a Schrotz-King, Petra  |m 1078258066:Schrotz-King, Petra  |p 3 
998 |g 1046823701  |a Cuk, Katarina  |m 1046823701:Cuk, Katarina  |d 50000  |e 50000PC1046823701  |k 0/50000/  |p 2 
998 |g 1151332208  |a Gies, Anton  |m 1151332208:Gies, Anton  |p 1  |x j 
999 |a KXP-PPN1567597440  |e 2993923188 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Anton Gies, Katarina Cuk, Petra Schrotz-King, and Hermann Brenner"]},"recId":"1567597440","note":["Gesehen am 25.01.2018","Article was first available online on 25 September 2017"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1567597440"],"doi":["10.1053/j.gastro.2017.09.018"]},"language":["eng"],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"physDesc":[{"extent":"12 S."}],"person":[{"role":"aut","given":"Anton","display":"Gies, Anton","family":"Gies"},{"role":"aut","given":"Katarina","family":"Cuk","display":"Cuk, Katarina"},{"family":"Schrotz-King","display":"Schrotz-King, Petra","given":"Petra","role":"aut"},{"given":"Hermann","family":"Brenner","display":"Brenner, Hermann","role":"aut"}],"title":[{"title_sort":"Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening","title":"Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screening"}],"relHost":[{"disp":"Direct comparison of diagnostic performance of 9 quantitative fecal immunochemical tests for colorectal cancer screeningGastroenterology","note":["Gesehen am 21.07.25"],"pubHistory":["Nachgewiesen 12.1949 -"],"recId":"270937293","corporate":[{"display":"American Gastroenterological Association","role":"isb"}],"language":["eng"],"id":{"eki":["270937293"],"issn":["1528-0012"],"zdb":["1478699-0"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"New York, NY ; Baltimore, Md. ; Philadelphia, Pa. [u.a.]","dateIssuedDisp":"1949-","publisher":"Elsevier ; Williams & Wilkins ; Saunders","dateIssuedKey":"1949"}],"part":{"pages":"93-104","text":"154(2018), 1, Seite 93-104","volume":"154","issue":"1","year":"2018","extent":"12"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Gastroenterology","subtitle":"official publication of the American Gastroenterological Association","title":"Gastroenterology"}]}]} 
SRT |a GIESANTONCDIRECTCOMP2018